SYNAPTICS Inc 4

Accession 0001209191-16-094949

$SYNACIK 0000817720operating

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 6:32 PM ET

Size

30.3 KB

Accession

0001209191-16-094949

Insider Transaction Report

Form 4

Period: 2016-01-29

SYNAPTICS IncSYNA

Deutsch Scott

SVP of Sales

Transactions

Exercise/Conversion
Employee Stock Option (Right to Buy)
2016-02-01−327→ 1,638 total
Exercise: $61.40Exp: 2021-04-28→ Common Stock (327 underlying)
Exercise/Conversion
Common Stock
2016-02-01$35.76/sh+1,389$49,671→ 9,525 total
Exercise/Conversion
Common Stock
2016-02-01$46.50/sh+327$15,206→ 9,852 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2016-02-01−327→ 983 total
Exercise: $46.50Exp: 2020-10-28→ Common Stock (327 underlying)
Tax Payment
Common Stock
2016-02-01$73.68/sh−629$46,345→ 8,136 total
Exercise/Conversion
Common Stock
2016-02-01$60.22/sh+327$19,692→ 10,179 total
Exercise/Conversion
Common Stock
2016-02-01$61.40/sh+327$20,078→ 10,506 total
Exercise/Conversion
Common Stock
2016-02-01$62.10/sh+339$21,054→ 10,845 total
Award
Employee Stock Option (Right to Buy)
2016-01-29+4,100→ 4,100 total
Exercise: $73.31Exp: 2023-01-29→ Common Stock (4,100 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2016-02-01−327→ 1,311 total
Exercise: $60.22Exp: 2021-01-27→ Common Stock (327 underlying)
Sale
Common Stock
2016-02-01$75.00/sh−1,320$99,000→ 9,525 total
Sale
Common Stock
2016-02-01$73.04/sh−1,389$101,453→ 8,136 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2016-02-01−1,389→ 0 total
Exercise: $35.76Exp: 2020-01-28→ Common Stock (1,389 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2016-02-01−339→ 2,378 total
Exercise: $62.10Exp: 2021-10-24→ Common Stock (339 underlying)

Footnotes (8)

[F1]Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units.
[F2]The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2015.
[F3]1/12th of the total number of shares subject to the option shall vest and become exercisable each quarter following the January 29, 2016 date of grant, until fully vested on January 29, 2019.
[F4]One-third of the total number of shares subject to the option vested and became exercisable on the 12-month anniversary of the January 28, 2013 grant date, and 1/36th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month thereafter, until fully vested on January 28, 2016.
[F5]1/12th of the total number of shares subject to the options vested or shall vest and became or shall become exercisable each quarter following the October 28, 2013 grant date, until fully vested on October 28, 2016.
[F6]1/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the January 27, 2014 date of grant, until fully vested on January 27, 2017.
[F7]1/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the April 28, 2014 date of grant, until fully vested on April 28, 2017.
[F8]1/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the October 24, 2014 date of grant, until fully vested on October 24, 2017.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

SYNAPTICS Inc

CIK 0000817720

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000817720

Filing Metadata

Form type: 4
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 6:32 PM ET
Size: 30.3 KB

View on SEC.gov